CARDIOGENIC SHOCK

This study is testing if a small sensor implanted in the lung artery can help manage patients recovering from severe heart failure shock. The device sends pressure data to doctors, aiming to catch problems early and prevent hospital readmissions. The trial will compare outcomes o…

This study tests if adding a small balloon pump (IABP) to a major heart-lung support machine (VA ECMO) helps patients with severe heart failure recover enough to be safely taken off the machine. It will involve 430 adults in cardiogenic shock who are on this advanced life support…

This study aims to find out if starting a kidney support machine earlier than usual is better for patients with severe heart failure who are also on a heart-lung life support machine. It will compare the safety and effectiveness of early treatment versus the standard timing in ab…

This study is testing a special heart-lung support machine used *before* a minimally invasive heart valve replacement in patients who are very unstable or have complex heart anatomy. The goal is to see if having this support ready in advance reduces the risk of death, cardiac arr…

This study is testing a new temporary heart pump device for patients experiencing cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood. The research aims to see if the device is safe and effective at stabilizing patients' blood pressure…

This study is testing if using a lower blood pressure target for patients in severe shock after a heart attack is better than the current standard. Researchers want to see if using less of a strong blood pressure medication (noradrenaline) helps patients survive and protects thei…

This study is testing if using a special catheter (a thin tube) to closely monitor heart pressures right away can help patients survive a dangerous condition called cardiogenic shock. It will compare this early, detailed monitoring to the current standard care, which often uses t…

This study is testing a temporary heart pump called the iVAC 2L to see if it can help patients survive and recover better from high-risk stent procedures. The pump is inserted through a leg artery and helps the heart pump blood during the delicate surgery. Researchers will follow…

This study is testing if starting a special advanced life support machine (called ECMO) right at the scene of a cardiac arrest is better than waiting until the patient reaches the hospital. It will compare survival and brain recovery in 90 patients. The main goal is to see if get…

This study aims to test the safety and effectiveness of a heart-lung support machine called the Cardiohelp System in children with life-threatening heart failure. It will also compare two different blood thinners used with the device. The goal is to gather enough evidence for the…

This study aims to understand if the stiffness of a patient's arteries can predict how well they respond to a temporary heart pump called an intra-aortic balloon pump. Researchers will observe 20 adults with severe heart failure (cardiogenic shock) who are already receiving this …

This study is creating a detailed registry to track the treatment and recovery of 500 patients with cardiogenic shock, a severe and often fatal heart condition. By following patients from four major medical centers for up to a year, researchers aim to identify which treatments an…

This study is collecting information to see if having a specialized team to treat cardiogenic shock—a life-threatening condition where the heart suddenly can't pump enough blood—leads to better patient survival. Researchers will look back at the medical records of up to 3000 adul…

This study aims to understand why some patients survive cardiogenic shock while others don't, by examining their genetic and immune system responses. Researchers will collect blood samples from 300 patients experiencing this life-threatening heart condition across European hospit…

This study is creating a large international registry to collect real-world data on how a medical device called CytoSorb is used in critical care. The device filters harmful substances from a patient's blood and is used for various severe conditions like septic shock, severe trau…

This study aims to understand the challenges faced by people who survive cardiogenic shock after they leave the hospital. It will follow 350 survivors to track their health, including how often they are readmitted to the hospital and their risk of death. The goal is to gather inf…